5 completed, 2 terminated, 1 withdrawn. 8 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 5, Terminated 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow Androgel: new trials by email Literature Review of Androgel trials Research Report on Androgel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men Nestorone® /testosterone gel, Testosterone only gel - Healthy | Phase 1 | Completed | Kimberly Myer | 44 | 2015-04-01 | 2025-02-13 |
| T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin Acyline, Testosterone 1.62% gel, Letrozole - Insulin Resistance, Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | Completed | University of Washington | 53 | 2013-06-01 | 2018-05-08 |
| ITT4 Intratesticular Hormonal Milieu in Man (ITT4) Acyline, Testosterone gel, ketoconazole 400 - Healthy Males | Phase 1 / Phase 2 | Completed | University of Washington | 46 | 2011-01-01 | 2014-03-31 |
| Influence of Male Hormones on Regional Fat Metabolism Leuprolide, Testosterone - Obesity | Phase 1 | Completed | Mayo Clinic | 39 | 2010-06-01 | 2014-05-14 |
| Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) Anastrozole Pill, Testosterone, Placebo Oral Tablet - Hypogonadotropic Hypogonadism, Kallmann Syndrome | Phase 1 | Terminated | Massachusetts General Hospital | 7 | 2010-05-01 | 2017-04-18 |
| Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome Zoladex, Testosterone gel, Anastrozole Pill - Metabolic Syndrome | Phase 1 | Terminated | Massachusetts General Hospital | 66 | 2006-09-01 | 2017-04-18 |
| A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED). testosterone gel, Comparator: placebo - Skin Androgenization | Phase 1 | Completed | Merck Sharp & Dohme LLC | 30 | 2004-10-01 | 2014-09-04 |
| Influence of Administration Route of Testosterone on Male Fertility MPP10, testosterone, Testosterone - Hypogonadism | Phase 1 | Withdrawn | Acerus Pharmaceuticals Corporation | 2018-03-13 |
Obesity (3) · Hypogonadism (2) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Idiopathic Hypogonadotropic Hypogonadism (1) · Insulin Resistance (1) · Kallmann Syndrome (1) · Metabolic Diseases (1) · Metabolic Syndrome (1) · Overweight (1)
Massachusetts General Hospital (2) · University of Washington (2) · Acerus Pharmaceuticals Corporation (1) · Kimberly Myer (1) · Mayo Clinic (1) · Merck Sharp & Dohme LLC (1)
United States (6) · Netherlands (1)
Christina Wang, MD (1) · Frances J Hayes, MD (1) · Katya Rubinow, MD (1) · Mara Y Roth, MD (1) · Margarita Budumian, MD (1) · Michael D Jensen, M.D. (1) · Nelly Pitteloud, MD (1) · Stephanie T Page, MD, PhD (1) · William Bremner, MD (1) · William J Bremner, MD, PhD (1)
PMID 23348398, PMID 27482750, PMID 29793828
R01DK045343 (1), U54HD012629 (1)